Accolade Statistics
Total Valuation
Vaxart has a market cap or net worth of 89.13 million. The enterprise value is 67.75 million.
| Market Cap | 89.13M |
| Enterprise Value | 67.75M |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vaxart has 228.21 million shares outstanding. The number of shares has increased by 41.57% in one year.
| Current Share Class | 228.21M |
| Shares Outstanding | 228.21M |
| Shares Change (YoY) | +41.57% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 0.88% |
| Owned by Institutions (%) | 11.98% |
| Float | 226.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.88 |
| PB Ratio | 1.95 |
| P/TBV Ratio | 2.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.17 |
| EV / Sales | 1.43 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.01 |
Financial Position
The company has a current ratio of 0.64, with a Debt / Equity ratio of 0.45.
| Current Ratio | 0.64 |
| Quick Ratio | 0.59 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.61 |
| Interest Coverage | -18.08 |
Financial Efficiency
Return on equity (ROE) is -114.74% and return on invested capital (ROIC) is -49.08%.
| Return on Equity (ROE) | -114.74% |
| Return on Assets (ROA) | -28.90% |
| Return on Invested Capital (ROIC) | -49.08% |
| Return on Capital Employed (ROCE) | -95.18% |
| Revenue Per Employee | 451,381 |
| Profits Per Employee | -553,543 |
| Employee Count | 105 |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Vaxart has paid 310,000 in taxes.
| Income Tax | 310,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.81% in the last 52 weeks. The beta is 1.13, so Vaxart's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -35.81% |
| 50-Day Moving Average | 0.44 |
| 200-Day Moving Average | 0.55 |
| Relative Strength Index (RSI) | 47.34 |
| Average Volume (20 Days) | 1,245,170 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.78 |
Income Statement
In the last 12 months, Vaxart had revenue of 47.40 million and -58.12 million in losses. Loss per share was -0.27.
| Revenue | 47.40M |
| Gross Profit | -38.55M |
| Operating Income | -57.16M |
| Pretax Income | -57.81M |
| Net Income | -58.12M |
| EBITDA | -48.24M |
| EBIT | -57.16M |
| Loss Per Share | -0.27 |
Balance Sheet
The company has 41.94 million in cash and 20.56 million in debt, giving a net cash position of 21.38 million or 0.09 per share.
| Cash & Cash Equivalents | 41.94M |
| Total Debt | 20.56M |
| Net Cash | 21.38M |
| Net Cash Per Share | 0.09 |
| Equity (Book Value) | 45.62M |
| Book Value Per Share | 0.20 |
| Working Capital | -35.86M |
Cash Flow
In the last 12 months, operating cash flow was -33.17 million and capital expenditures -553,000, giving a free cash flow of -33.73 million.
| Operating Cash Flow | -33.17M |
| Capital Expenditures | -553,000 |
| Free Cash Flow | -33.73M |
| FCF Per Share | -0.15 |
Margins
Gross margin is -81.34%, with operating and profit margins of -120.60% and -122.63%.
| Gross Margin | -81.34% |
| Operating Margin | -120.60% |
| Pretax Margin | -121.98% |
| Profit Margin | -122.63% |
| EBITDA Margin | -101.78% |
| EBIT Margin | -120.60% |
| FCF Margin | n/a |
Dividends & Yields
Vaxart does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.57% |
| Shareholder Yield | n/a |
| Earnings Yield | -65.21% |
| FCF Yield | -37.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Vaxart has an Altman Z-Score of -4.67 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.67 |
| Piotroski F-Score | 4 |